Treatment

Gout, a prevalent inflammatory arthritis, is triggered by monosodium urate (MSU) crystal deposits in joints due to elevated serum urate (SU) levels. This causes intense pain and swelling,...
CURATED BY: Cristina Perez,
RN, MSN, FNP-C

Study Identifies Optimal eGFR for Dialysis Initiation in Advanced Chronic Kidney Disease

Researchers of this study aimed to determine the optimal estimated glomerular filtration rate (eGFR) for initiating dialysis in patients with...
CURATED BY:
Stephen Thomas,
FNP-C, MSN, RN

New Technologies Offer Hope for Patients With End-Stage Renal Disease Amidst Donor Organ Shortage

Over two million people globally suffer from end-stage renal disease (ESRD), with kidney transplants being the best treatment option. However,...
CURATED BY:
Cristina Perez,
RN, MSN, FNP-C

EMPA-KIDNEY Trial Shows Empagliflozin Reduces CKD Progression and Cardio Risks

The EMPA-KIDNEY trial evaluated empagliflozin's effectiveness in patients with chronic kidney disease (CKD) at various stages of progression. Participants with...
CURATED BY:
Kimberly Cantillon,
MPAS, PA-C

Advancing Therapies: Non-Steroidal MR Antagonists in the Spotlight for Treating Chronic Conditions

MR overactivation, implicated in various pathologies including chronic kidney disease (CKD) and type 2 diabetes mellitus, underscores the importance of...
CURATED BY:
Kimberly Cantillon,
MPAS, PA-C

Finerenone Promising for Reducing CKD and Cardiovascular Risks in Type 2 Diabetes

In a double-blind trial involving 5734 patients with chronic kidney disease (CKD) and type 2 diabetes, finerenone, a selective mineralocorticoid...
CURATED BY:
Kimberly Cantillon,
MPAS, PA-C

Finerenone Reduces Heart, Kidney Risks in Diabetes CKD Study

The FIDELITY analysis consolidated data from the FIDELIO-DKD and FIGARO-DKD studies, targeting patients with type 2 diabetes across different stages...
CURATED BY:
Kimberly Cantillon,
MPAS, PA-C
Share